7Baggers

Abbott Laboratories Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 01.73.45.16.88.510.211.89Billion

Abbott Laboratories Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 
                                                       
  net sales11,142,000,000 10,358,000,000 10,974,000,000 10,635,000,000 10,377,000,000 9,964,000,000 10,241,000,000 10,143,000,000 9,978,000,000 9,747,000,000 10,091,000,000 10,410,000,000 11,257,000,000 11,895,000,000 11,468,000,000 10,928,000,000 10,223,000,000 10,456,000,000 10,701,000,000 8,853,000,000 7,328,000,000 7,726,000,000    7,535,000,000 7,656,000,000 7,767,000,000 7,390,000,000 6,829,000,000 6,637,000,000 6,335,000,000 5,302,000,000 5,333,000,000 4,885,000,000 5,150,000,000 5,170,000,000 4,897,000,000 5,104,000,000 5,551,000,000 5,244,000,000 5,369,138,000 5,446,025,000 5,377,895,000 9,773,241,000 9,807,100,000 9,456,633,000 9,816,665,000 9,616,291,000 9,040,850,000 8,674,505,000 8,826,014,000 7,698,354,000 
  yoy7.37% 3.95% 7.16% 4.85% 4.00% 2.23% 1.49% -2.56% -11.36% -18.06% -12.01% -4.74% 10.11% 13.76% 7.17% 23.44% 39.51% 35.34%    2.53%    10.34% 15.35% 22.60% 39.38% 28.05% 35.86% 23.01% 2.55% 8.90% -4.29% -7.22% -1.41% -8.79% -6.28% 3.22% -46.34% -45.25% -42.41% -45.22% 1.63% 8.48% 9.02% 11.22% 24.91%     
  qoq7.57% -5.61% 3.19% 2.49% 4.14% -2.70% 0.97% 1.65% 2.37% -3.41% -3.06% -7.52% -5.36% 3.72% 4.94% 6.90% -2.23% -2.29% 20.87% 20.81% -5.15%     -1.58% -1.43% 5.10% 8.21% 2.89% 4.77% 19.48% -0.58% 9.17% -5.15% -0.39% 5.57% -4.06% -8.05% 5.85% -2.33% -1.41% 1.27% -44.97% -0.35% 3.71% -3.67% 2.08% 6.36% 4.22% -1.72% 14.65%  
  cost of products sold, excluding amortization of intangible assets4,854,000,000 4,468,000,000 4,942,000,000 4,698,000,000 4,603,000,000 4,463,000,000 4,556,000,000 4,605,000,000 4,483,000,000 4,331,000,000 4,593,000,000 4,629,000,000 4,933,000,000 4,987,000,000 4,766,000,000 4,423,000,000 4,947,000,000 4,401,000,000 4,493,000,000 3,966,000,000 3,263,000,000 3,281,000,000    3,160,000,000 3,166,000,000 3,282,000,000 3,067,000,000 2,857,000,000 3,173,000,000 3,044,000,000 2,285,000,000 2,287,000,000 2,140,000,000 2,242,000,000 2,218,000,000 2,081,000,000 2,331,000,000 2,506,000,000 2,470,000,000             
  amortization of intangible assets420,000,000 420,000,000 465,000,000 470,000,000 471,000,000 472,000,000 481,000,000 496,000,000 498,000,000 491,000,000 496,000,000 498,000,000 507,000,000 512,000,000 514,000,000 520,000,000 504,000,000 509,000,000 508,000,000 510,000,000 553,000,000 561,000,000    486,000,000 544,000,000 562,000,000 584,000,000 501,000,000 392,000,000 522,000,000 140,000,000 145,000,000 144,000,000 151,000,000 151,000,000 156,000,000 132,000,000 161,000,000 174,000,000 196,697,000 196,892,000 199,422,000          
  research and development725,000,000 716,000,000 749,000,000 713,000,000 698,000,000 684,000,000 700,000,000 672,000,000 715,000,000 654,000,000 725,000,000 782,000,000 684,000,000 697,000,000 762,000,000 672,000,000 654,000,000 654,000,000 698,000,000 580,000,000 564,000,000 578,000,000    672,000,000 574,000,000 575,000,000 589,000,000 562,000,000 513,000,000 547,000,000 352,000,000 348,000,000 379,000,000 378,000,000 345,000,000 313,000,000 307,000,000 335,000,000 387,000,000 356,877,000 362,557,000 346,323,000 1,164,187,000 1,010,882,000 1,005,682,000 1,009,627,000 1,037,780,000 930,400,000 1,078,927,000 857,698,000 730,367,000 
  selling, general and administrative3,091,000,000 3,061,000,000 2,907,000,000 2,895,000,000 2,936,000,000 2,959,000,000 2,724,000,000 2,723,000,000 2,740,000,000 2,762,000,000 2,973,000,000 2,731,000,000 2,757,000,000 2,787,000,000 3,048,000,000 2,767,000,000 2,726,000,000 2,783,000,000 2,570,000,000 2,302,000,000 2,276,000,000 2,548,000,000    2,478,000,000 2,377,000,000 2,466,000,000 2,542,000,000 2,099,000,000 2,132,000,000 2,424,000,000 1,628,000,000 1,737,000,000 1,698,000,000 1,666,000,000 1,727,000,000 1,737,000,000 1,603,000,000 1,788,000,000 1,762,000,000 1,734,693,000 1,714,275,000 1,785,559,000 2,921,923,000 2,944,492,000 3,000,308,000 4,238,910,000 2,762,086,000 2,850,318,000 2,673,277,000 2,743,418,000 2,162,400,000 
  total operating cost and expenses9,090,000,000 8,665,000,000 9,063,000,000 8,776,000,000 8,708,000,000 8,578,000,000 8,461,000,000 8,496,000,000 8,436,000,000 8,238,000,000 8,787,000,000 8,640,000,000 8,881,000,000 8,983,000,000 9,090,000,000 8,382,000,000 8,831,000,000 8,347,000,000 8,269,000,000 7,358,000,000 6,656,000,000 6,968,000,000    6,796,000,000 6,661,000,000 6,885,000,000 6,782,000,000 6,019,000,000 6,210,000,000 6,537,000,000 4,405,000,000 4,517,000,000 4,361,000,000 4,437,000,000 4,441,000,000 4,287,000,000 4,373,000,000 4,790,000,000 4,793,000,000 4,738,799,000 4,818,549,000 4,763,107,000 7,784,188,000 7,702,679,000 7,880,911,000 9,221,787,000 7,842,838,000 7,739,701,000 7,493,320,000 7,220,048,000 6,227,871,000 
  operating earnings2,052,000,000 1,693,000,000 1,911,000,000 1,859,000,000 1,669,000,000 1,386,000,000 1,780,000,000 1,647,000,000 1,542,000,000 1,509,000,000 1,304,000,000 1,770,000,000 2,376,000,000 2,912,000,000 2,378,000,000 2,546,000,000 1,392,000,000 2,109,000,000 2,432,000,000 1,495,000,000 672,000,000 758,000,000    739,000,000 995,000,000 882,000,000 608,000,000 810,000,000 427,000,000  897,000,000 816,000,000 524,000,000 713,000,000 729,000,000 610,000,000 731,000,000 761,000,000 451,000,000 630,339,000 627,476,000 614,788,000 1,989,053,000 2,104,421,000 1,575,722,000 594,878,000 1,773,453,000 1,301,149,000 1,181,185,000 1,605,966,000 1,470,483,000 
  yoy22.95% 22.15% 7.36% 12.87% 8.24% -8.15% 36.50% -6.95% -35.10% -48.18% -45.16% -30.48% 70.69% 38.07% -2.22% 70.30% 107.14% 178.23%    2.57%    -8.77% 133.02%  -32.22% -0.74% -18.51%  23.05% 33.77% -28.32% -6.31% 61.64% -3.23% 16.50% 23.78% -77.33% -70.05% -60.18% 3.35% 12.16% 61.74% 33.40% -62.96% 20.60%     
  qoq21.20% -11.41% 2.80% 11.38% 20.42% -22.13% 8.08% 6.81% 2.19% 15.72% -26.33% -25.51% -18.41% 22.46% -6.60% 82.90% -34.00% -13.28% 62.68% 122.47% -11.35%     -25.73% 12.81% 45.07% -24.94% 89.70%   9.93% 55.73% -26.51% -2.19% 19.51% -16.55% -3.94% 68.74% -28.45% 0.46% 2.06% -69.09% -5.48% 33.55% 164.88% -66.46% 36.30% 10.16% -26.45% 9.21%  
  operating margin %18.42% 16.34% 17.41% 17.48% 16.08% 13.91% 17.38% 16.24% 15.45% 15.48% 12.92% 17.00% 21.11% 24.48% 20.74% 23.30% 13.62% 20.17% 22.73% 16.89% 9.17% 9.81%    9.81% 13.00% 11.36% 8.23% 11.86% 6.43%  16.92% 15.30% 10.73% 13.84% 14.10% 12.46% 14.32% 13.71% 8.60% 11.74% 11.52% 11.43% 20.35% 21.46% 16.66% 6.06% 18.44% 14.39% 13.62% 18.20% 19.10% 
  interest expense121,000,000 131,000,000 136,000,000 142,000,000 140,000,000 141,000,000 159,000,000 166,000,000 159,000,000 153,000,000 154,000,000 141,000,000 132,000,000 131,000,000 131,000,000 133,000,000 134,000,000 135,000,000 136,000,000 137,000,000 134,000,000 139,000,000    171,000,000 203,000,000 210,000,000 227,000,000 218,000,000 214,000,000 226,000,000 117,000,000 103,000,000 58,000,000 41,000,000 44,000,000 37,000,000 35,000,000 39,000,000 39,000,000 39,799,000 40,526,000 40,757,000 152,034,000 127,191,000 126,866,000 124,339,000 134,129,000 145,587,000 149,102,000 134,488,000 118,201,000 
  interest-71,000,000 -82,000,000 -63,250,000 -91,000,000 -82,000,000 -80,000,000 -74,000,000 -97,000,000 -98,000,000 -101,000,000 -23,750,000 -55,000,000 -26,000,000 -14,000,000 -8,000,000 -10,000,000 -11,000,000 -11,000,000 -9,250,000 -10,000,000 -9,000,000 -18,000,000                                
  net foreign exchange (gain) loss-11,000,000 -7,000,000 -10,000,000 -11,000,000 -6,000,000  24,000,000 -10,000,000 21,000,000 6,000,000 -14,000,000 19,000,000  -3,000,000 -6,000,000 4,000,000  3,000,000 -5,000,000 -7,000,000 -1,000,000 5,000,000    6,000,000 11,000,000                           
  other income-137,000,000 -127,000,000 -154,000,000 -121,000,000 10,000,000 -111,000,000 -109,000,000 -83,000,000 -176,000,000 -111,000,000 -68,000,000 -93,000,000 -82,000,000 -78,000,000 -63,000,000 -74,000,000 -79,000,000 -61,000,000 -78,000,000 -46,000,000 22,000,000 -1,000,000     18,000,000        19,000,000     3,000,000 3,000,000   5,665,000  8,528,000    140,858,000 4,519,000   
  earnings before taxes2,150,000,000 1,778,000,000 2,030,000,000 1,940,000,000 1,607,000,000 1,436,000,000 1,795,000,000 1,671,000,000 1,636,000,000 1,562,000,000 1,746,500,000 1,758,000,000 2,352,000,000 2,876,000,000                               1,872,384,000 2,003,317,000 1,513,029,000 501,595,000 1,674,556,000 1,068,786,000 1,064,110,000 1,558,687,000 1,322,207,000 
  taxes on earnings371,000,000 453,000,000 -7,199,000,000 294,000,000 305,000,000 211,000,000 201,000,000 235,000,000 261,000,000 244,000,000 271,500,000 323,000,000 334,000,000 429,000,000                                278,705,000 270,905,000 198,414,000  204,968,000 173,450,000 267,037,000 319,192,000 
  net earnings1,779,000,000 1,325,000,000 9,229,000,000 1,646,000,000 1,302,000,000 1,225,000,000 1,594,000,000 1,436,000,000 1,375,000,000 1,318,000,000 1,033,000,000 1,435,000,000 2,018,000,000 2,447,000,000 1,989,000,000 2,100,000,000 1,189,000,000 1,793,000,000 2,162,000,000 1,232,000,000 537,000,000 564,000,000    672,000,000 563,000,000 733,000,000 418,000,000 603,000,000 283,000,000 419,000,000 -329,000,000 615,000,000 316,000,000 580,000,000 784,000,000 2,292,000,000 538,000,000 466,000,000 375,000,000 965,734,000 476,055,000 544,661,000 1,942,806,000 1,724,612,000 1,242,124,000 303,181,000 1,942,782,000 863,818,000 890,660,000 1,291,650,000 1,003,015,000 
  yoy36.64% 8.16% 478.98% 14.62% -5.31% -7.06% 54.31% 0.07% -31.86% -46.14% -48.06% -31.67% 69.72% 36.48% -8.00% 70.45% 121.42% 217.91%    -16.07%    11.44% 98.94% 74.94% -227.05% -1.95% -10.44% -27.76% -141.96% -73.17% -41.26% 24.46% 109.07% 137.33% 13.01% -14.44% -80.70% -44.00% -61.67% 79.65% 0.00% 99.65% 39.46% -76.53% 93.69%     
  qoq34.26% -85.64% 460.69% 26.42% 6.29% -23.15% 11.00% 4.44% 4.32% 27.59% -28.01% -28.89% -17.53% 23.03% -5.29% 76.62% -33.69% -17.07% 75.49% 129.42% -4.79%     19.36% -23.19% 75.36% -30.68% 113.07% -32.46% -227.36% -153.50% 94.62% -45.52% -26.02% -65.79% 326.02% 15.45% 24.27% -61.17% 102.86% -12.60% -71.97% 12.65% 38.84% 309.70% -84.39% 124.91% -3.01% -31.04% 28.78%  
  net income margin %15.97% 12.79% 84.10% 15.48% 12.55% 12.29% 15.56% 14.16% 13.78% 13.52% 10.24% 13.78% 17.93% 20.57% 17.34% 19.22% 11.63% 17.15% 20.20% 13.92% 7.33% 7.30%    8.92% 7.35% 9.44% 5.66% 8.83% 4.26% 6.61% -6.21% 11.53% 6.47% 11.26% 15.16% 46.80% 10.54% 8.39% 7.15% 17.99% 8.74% 10.13% 19.88% 17.59% 13.13% 3.09% 20.20% 9.55% 10.27% 14.63% 13.03% 
  basic earnings per common share1,020,000 760,000 5,280,000 940,000 740,000 700,000 920,000 820,000 790,000 750,000 837,500 820,000 1,150,000 1,380,000                               1,220 1,090 790 190 1,240 560 580 830 650 
  diluted earnings per common share1,010,000 760,000 5,260,000 940,000 740,000 700,000 910,000 820,000 780,000 750,000 830,000 810,000 1,140,000 1,370,000                               1,210 1,080 780 190 1,230 550 570 830 640 
  average number of common shares outstanding used for basic earnings per common share1,743,437,000,000 1,739,206,000,000 -1,739,129,000,000 1,739,466,000,000 1,743,040,000,000 1,740,203,000,000 -1,738,515,000,000 1,738,700,000,000 1,740,359,000,000 1,741,738,000,000 -1,754,456,000,000 1,752,968,000,000 1,753,865,000,000 1,761,911,000,000 -1,775,095,000,000 1,774,516,000,000 1,779,203,000,000 1,776,842,000,000 -1,770,393,000,000 1,774,475,000,000 1,772,953,000,000 1,768,901,000,000    1,763,278,000,000 1,759,585,000,000 1,757,836,000,000 1,753,412,000,000 1,743,757,000,000 1,740,524,000,000 1,727,356,000,000 1,476,366,000,000 1,474,504,000,000 1,477,332,000,000 1,495,465,000,000 1,493,771,000,000 1,504,995,000,000 1,508,596,000,000 1,506,595,000,000 1,532,810,000,000 1,551,803,000 1,560,519,000 1,568,730,000 1,576,771,000 1,572,099,000 1,573,921,000 1,558,556,000 1,556,869,000 1,551,755,000 1,545,413,000 1,544,415,000 1,547,815,000 
  dilutive common stock options7,398,000,000 8,014,000,000 -8,557,000,000 8,131,000,000 8,113,000,000 9,449,000,000 -9,810,000,000 9,589,000,000 9,889,000,000 9,977,000,000 -11,627,000,000 10,685,000,000 11,598,000,000 12,631,000,000 -14,393,000,000 14,483,000,000 14,076,000,000 14,661,000,000 -12,368,000,000 13,378,000,000 12,087,000,000 11,677,000,000    13,295,000,000 12,095,000,000 11,114,000,000 11,866,000,000 10,399,000,000 8,359,000,000 7,839,000,000  5,988,000,000 6,341,000,000 9,702,000,000 10,444,000,000 10,542,000,000                
  average number of common shares outstanding plus dilutive common stock options1,750,835,000,000 1,747,220,000,000 -1,747,686,000,000 1,747,597,000,000 1,751,153,000,000 1,749,652,000,000 -1,748,325,000,000 1,748,289,000,000 1,750,248,000,000 1,751,715,000,000 -1,766,083,000,000 1,763,653,000,000 1,765,463,000,000 1,774,542,000,000 -1,789,488,000,000 1,788,999,000,000 1,793,279,000,000 1,791,503,000,000 -1,782,761,000,000 1,787,853,000,000 1,785,040,000,000 1,780,578,000,000    1,776,573,000,000 1,771,680,000,000 1,768,950,000,000 1,765,278,000,000 1,754,156,000,000 1,748,883,000,000 1,735,195,000,000 1,476,366,000,000 1,480,492,000,000 1,483,673,000,000 1,505,167,000,000 1,504,215,000,000 1,515,537,000,000                
  outstanding common stock options having no dilutive effect1,442,000,000 1,431,000,000 -6,885,000,000 6,905,000,000 8,855,000,000 6,892,000,000 -5,469,000,000 7,334,000,000 5,474,000,000 7,332,000,000 -2,652,000,000 5,445,000,000 5,419,000,000 2,655,000,000 673,500,000 2,740,000,000 2,720,000,000 2,694,000,000   50,000,000 4,035,000,000    4,011,000,000 44,000,000 93,000,000  282,000,000 5,258,000,000 9,432,000,000 12,103,000,000 5,673,000,000 5,881,000,000 717,000,000 658,000,000 5,263,000,000 535,000,000 544,000,000 4,421,000,000 1,601,000 1,015,000 5,518,000 1,720,000 1,166,000 3,066,000 61,201,000 60,653,000 63,202,000 66,479,000 66,601,000 29,403,000 
  ​                                                     
  earnings from continuing operations before taxes              2,327,000,000 2,493,000,000 1,348,000,000  2,388,000,000 1,421,000,000 526,000,000      718,000,000 777,000,000  626,000,000 295,000,000   715,000,000  714,000,000 986,000,000 653,000,000 718,000,000 737,000,000 423,000,000 628,395,000 600,749,000 554,551,000          
  tax benefit on earnings from continuing operations              200,500,000 393,000,000 159,000,000    -11,000,000 89,000,000                                
  earnings from continuing operations              1,989,000,000 2,100,000,000 1,189,000,000 1,793,000,000 2,158,000,000 1,232,000,000 537,000,000 544,000,000    672,000,000 552,000,000 718,000,000 409,000,000 561,000,000 270,000,000 386,000,000  599,000,000 56,000,000 596,000,000 786,000,000 529,000,000 440,000,000 460,000,000 339,000,000 772,863,000 476,055,000 544,661,000          
  earnings from discontinued operations, net of tax                  5,000,000   20,000,000     11,000,000 15,000,000 9,000,000 42,000,000 13,000,000 33,000,000 28,000,000 16,000,000 244,000,000   26,000,000   36,000,000             
  basic earnings per common share —                                                     
  continuing operations              1,120,000 1,180,000 670,000 1,000,000 1,210,000 690,000 300,000 310,000    380,000 310,000 410,000 230,000 320,000 150,000 220,000 -240,000 400,000 40,000 400,000 520,000 350,000 290,000 300,000 220,000 500 300 350          
  discontinued operations                     10,000     10,000 10,000 10,000 20,000 10,000 20,000 20,000 10,000 170,000   1,170,000 70,000  20,000 120            
  diluted earnings per common share —                                                     
  earnings from continuing operations before tax                 2,043,000,000    633,000,000    632,000,000   431,000,000   736,000,000   2,000,000                   
  tax expense on earnings from continuing operations                 250,000,000 66,750,000 189,000,000         22,000,000                         
  net income on extinguishment of debt                          67,000,000  14,000,000                         
  taxes on earnings from continuing operations                          166,000,000 59,000,000  65,000,000 25,000,000  178,000,000 116,000,000  118,000,000 200,000,000 124,000,000 278,000,000 277,000,000 84,000,000  124,694,000 9,890,000          
  cash dividends declared per common share                          280,000 280,000 280,000 265,000 265,000 265,000 260,000 260,000 260,000 240,000 240,000 240,000 220,000 220,000 220,000 140 140 140 510 510 510 480 480 480 440 440 440 
  net foreign exchange gain                                9,000,000 10,000,000 478,000,000  5,000,000                70,019,000 
  other income (income)                             8,000,000   972,000,000 8,000,000                    
  gain on sale of discontinued operations, net of tax                                  16,000,000 16,000,000  1,737,000,000                
  net earnings from discontinued operations, net of tax                             42,000,000 13,000,000 33,000,000 28,000,000 16,000,000 260,000,000   1,763,000,000                
  tax (benefit) expense on earnings from continuing operations                               350,000,000                      
  earnings from discontinued operations, net of taxes                                      98,000,000 6,000,000  192,871,000            
  net foreign exchange loss                                       1,000,000 2,000,000 4,599,000 10,748,000 28,865,000   24,762,000       
  dilutive common stock options and awards                                      11,184,000,000 10,451,000,000 14,881,000,000 14,888,000 16,165,000 17,288,000 17,508,000 16,403,000 15,589,000 9,731,000 9,234,000 6,886,000 8,639,000 7,367,000 13,508,000 
  average number of common shares outstanding plus dilutive common stock options and awards                                      1,519,780,000,000 1,517,046,000,000 1,547,691,000,000 1,566,691,000 1,576,684,000 1,586,018,000 1,594,279,000 1,588,502,000 1,589,510,000 1,568,287,000 1,566,103,000 1,558,641,000 1,554,052,000 1,551,782,000 1,561,323,000 
  cost of products sold                                         2,450,532,000 2,544,825,000 2,431,803,000 3,698,078,000 3,637,305,000 3,724,921,000 3,973,250,000 3,870,472,000 3,858,983,000 3,741,116,000 3,543,932,000 3,335,104,000 
  acquired in-process and collaborations research and development                                             110,000,000 150,000,000       
  acquired in-process research and development                                                172,500,000 100,000,000  75,000,000  

We provide you with 20 years income statements for Abbott Laboratories stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Abbott Laboratories stock. Explore the full financial landscape of Abbott Laboratories stock with our expertly curated income statements.

The information provided in this report about Abbott Laboratories stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.